MGX-292

N/A

Report date: 2024/05/14 17:06:09

Base Information

Drug NameMGX-292
Drug Alias NameRecombinant BMP 9 (Centessa Pharmaceuticals)MGX-292
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGrowth differentiation factor 2 replacements
TargetsGrowth/differentiation factor 2
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesCentessa Pharmaceuticals Plc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A